World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
30321
World Ranking
12190
National Ranking
142

Overview

Jean-Jacques Body is affiliated with the Université Libre de Bruxelles in Belgium, focusing on medical research with an emphasis on orthopedics, sports medicine, surgery, oncology, molecular biology, and pathology and forensic medicine. Their body of work comprises over 100 publications primarily in the field of medicine.

The research topics covered by Jean-Jacques Body include:

  • Bone health and osteoporosis research
  • Hip and femur fractures
  • Bone health and treatments
  • Bone and joint diseases
  • Bone metabolism and diseases
  • Vitamin D research studies
  • Management of metastatic bone disease

Jean-Jacques Body has collaborated frequently with several researchers, including Felicia Baleanu, Laura Iconaru, Murielle Surquin, P. Bergmann, and Florence Benoit. These partnerships reflect a consistent engagement within their research community.

Common publication venues for Jean-Jacques Body's work include:

  • Bone Reports
  • Osteoporosis International
  • The Journal of Clinical Endocrinology & Metabolism
  • Calcified Tissue International
  • Journal of Bone Oncology

Notable recent papers authored or co-authored include:

  • "Bone health in cancer: ESMO Clinical Practice Guidelines" (2020), Annals of Oncology
  • "Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS" (2020), The Journal of Clinical Endocrinology & Metabolism
  • "Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomized clinical trials" (2023), BMJ
  • "How to manage osteoporosis before the age of 50" (2020), Maturitas
  • "Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases" (2022), Calcified Tissue International

Best Publications

  • Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

    Alison T. Stopeck;Allan Lipton;Jean Jacques Body;Guenther G. Steger

  • Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

    Ian R. Reid;Jacques P. Brown;Peter Burckhardt;Zebulun Horowitz

  • Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

    P Major;Alain Lortholary;J. Hon;E Abdi

  • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.

    Jean Claude Souberbielle;Jean Jacques Body;Joan M. Lappe;Mario Plebani

  • A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

    Jean Jacques Body;Thierry Facon;Robert E. Coleman;Allan Lipton

  • Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

    Karim Fizazi;Allan Lipton;Xavier Mariette;Jean-Jacques Body

  • Bone health in cancer patients: ESMO Clinical Practice Guidelines

    R Coleman;Jean-Jacques Body;M Aapro;P Hadji

  • Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    M. Aapro;P. A. Abrahamsson;J. J. Body;R. E. Coleman

  • Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

    J.-J. Body;I. J. Diel;M. R. Lichinitser;E. D. Kreuser

  • Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.

    David L. Kendler;Fernando Marin;Cristiano A. F. Zerbini;Luis A. Russo

  • Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.

    Jean-Jacques Body;R. Bartl;Peter Burckhardt;P.D. Delmas

  • A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

    Jean-Jacques Body M.D.;Philip Greipp;Robert E. Coleman;Thierry Facon

  • A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.

    Jean-Jacques Body;Gregory A. Gaich;Wim H. Scheele;Pandurang M. Kulkarni

  • Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

    Allan Lipton;Guenther G. Steger;Jazmin Figueroa;Cristina Alvarado

  • Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

    J J Body;I J Diel;M Lichinitzer;A Lazarev

  • Bisphosphonates induce breast cancer cell death in vitro.

    Olivia Fromigue;Laurence Lagneaux;Jean-Jacques Body

  • Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.

    V. Grill;P. Ho;J. J. Body;N. Johanson

  • BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES

    R. Coleman;P. Hadji;J.-J. Body;D. Santini

  • Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer

    Diana L. Ersfeld;D. Sudhaker Rao;Jean Jacques Body;James L. Sackrison

  • Practical guidance for the management of aromatase inhibitor-associated bone loss

    P. Hadji;J.-J. Body;M.S. Aapro;A. Brufsky

Frequent Co-Authors

Allan Lipton
Allan Lipton Penn State Milton S. Hershey Medical Center
Robert E. Coleman
Robert E. Coleman University of Sheffield
Marianne Paesmans
Marianne Paesmans Université Libre de Bruxelles
Jean-Pierre Devogelaer
Jean-Pierre Devogelaer Université Catholique de Louvain
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Denis Larsimont
Denis Larsimont Université Libre de Bruxelles
Matti Aapro
Matti Aapro European CanCer Organisation
Steven Boonen
Steven Boonen KU Leuven
Jean-Paul Sculier
Jean-Paul Sculier Université Libre de Bruxelles
Olivier Bruyère
Olivier Bruyère University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is highly rewarding, there are several alternative and related career pathways to consider, especially in the field of nursing. The flexibility of online programs now makes it easier for students and working professionals to advance their education and careers without relocating.

For those interested in nursing leadership or academic roles, an online PhD in nursing offers an affordable pathway to a terminal degree in the profession. Similarly, registered nurses looking to move up can benefit from learning about the average cost of rn to bsn programs to find cost-effective bachelor's degree options online.

If you hold a non-nursing degree but wish to transition into nursing, exploring direct entry msn programs online can help you qualify for advanced roles faster. Additionally, prospective students who are concerned about admission requirements can find accessible programs by researching easy nursing schools to get into.

Exploring these online degrees and alternative pathways can help you align your career goals with a flexible, affordable educational plan.

Best Scientists Citing Jean-Jacques Body

Trending Scientists

Recently Published Articles